Mechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome

被引:10
作者
Bulow, Pernille [1 ,3 ]
Segal, Menahem [2 ]
Bassell, Gary J. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA
[2] Weizmann Inst Sci, Dept Brain Sci, IL-76100 Rehovot, Israel
[3] iMotions Inc, Boston, MA 02114 USA
关键词
Fragile X Syndrome; the Fragile X Messenger Ribonucleoprotein; FMRP; FMR1; hyperexcitability; homeostatic plasticity; ion channels; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; MESSENGER-RNA; HOMEOSTATIC PLASTICITY; GABA(A) RECEPTOR; SYNAPTIC PLASTICITY; DEPENDENT REGULATION; POTASSIUM CHANNELS; DENDRITIC SPINES; SODIUM CURRENT;
D O I
10.3390/ijms23116315
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperexcitability is a shared neurophysiological phenotype across various genetic neurodevelopmental disorders, including Fragile X syndrome (FXS). Several patient symptoms are associated with hyperexcitability, but a puzzling feature is that their onset is often delayed until their second and third year of life. It remains unclear how and why hyperexcitability emerges in neurodevelopmental disorders. FXS is caused by the loss of FMRP, an RNA-binding protein which has many critical roles including protein synthesis-dependent and independent regulation of ion channels and receptors, as well as global regulation of protein synthesis. Here, we discussed recent literature uncovering novel mechanisms that may drive the progressive onset of hyperexcitability in the FXS brain. We discussed in detail how recent publications have highlighted defects in homeostatic plasticity, providing new insight on the FXS brain and suggest pharmacotherapeutic strategies in FXS and other neurodevelopmental disorders.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders
    De Rubeis, Silvia
    Bagni, Claudia
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2011, 3 (03) : 257 - 269
  • [22] Fragile X syndrome: from molecular genetics to therapy
    D'Hulst, C.
    Kooy, R. F.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 (09) : 577 - 584
  • [23] Fragile X syndrome: from gene discovery to therapy
    Heulens, Inge
    Kooy, Frank
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1211 - 1232
  • [24] Fragile X syndrome: Are signaling lipids the missing culprits?
    Tabet, Ricardos
    Vitale, Nicolas
    Moine, Herve
    BIOCHIMIE, 2016, 130 : 188 - 194
  • [25] Developmental changes in expression of inhibitory neuronal proteins in the Fragile X Syndrome mouse basolateral amygdala
    Kratovac, Sebila
    Corbin, Joshua G.
    BRAIN RESEARCH, 2013, 1537 : 69 - 78
  • [26] Macro Role(s) of MicroRNAs in Fragile X Syndrome?
    Li, Xuekun
    Jin, Peng
    NEUROMOLECULAR MEDICINE, 2009, 11 (03) : 200 - 207
  • [27] APP Causes Hyperexcitability in Fragile X Mice
    Westmark, Cara J.
    Chuang, Shih-Chieh
    Hays, Seth A.
    Filon, Mikolaj J.
    Ray, Brian C.
    Westmark, Pamela R.
    Gibson, Jay R.
    Huber, Kimberly M.
    Wong, Robert K. S.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
  • [28] An "Omic" Overview of Fragile X Syndrome
    Dionne, Olivier
    Corbin, Francois
    BIOLOGY-BASEL, 2021, 10 (05):
  • [29] Translational endpoints in fragile X syndrome
    de Esch, Celine E. F.
    Zeidler, Shimriet
    Willemsen, Rob
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 256 - 269
  • [30] Fragile X syndrome: An aging perspective
    Schneider, Andrea
    Ligsay, Andrew
    Hagerman, Randi J.
    DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2013, 18 (01) : 68 - 74